Assessing the role of everolimus in reducing hepatocellular carcinoma recurrence after living donor liver transplantation for patients within the UCSF criteria: re-inventing the role of mammalian target of rapamycin inhibitors

BACKGROUNDS/AIMS: The protective effect of everolimus (EVR) in hepatocellular carcinoma (HCC) patients who receive liver transplantation in terms of reducing the recurrence has not been sufficiently investigated in clinical trials. In this second stage of our ongoing study, we intend to analyze the...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ann Hepatobiliary Pancreat Surg
Главные авторы: Thorat, Ashok, Jeng, Long-Bin, Yang, Horng-Ren, Yeh, Chun-Chieh, Hsu, Shih-Chao, Chen, Te-Hung, Poon, Kin-Shing
Формат: Artigo
Язык:Inglês
Опубликовано: Korean Association of Hepato-Biliary-Pancreatic Surgery 2017
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5736740/
https://ncbi.nlm.nih.gov/pubmed/29264583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14701/ahbps.2017.21.4.205
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы